Research Overview

Donald Ingber is interested in how cell structure and mechanics impact cellular biochemistry and tissue development. His research approach has combined techniques from various fields, including molecular cell biology, engineering, chemistry, physics, and computer science.

Ingber's angiogenesis research focuses on how the shape of a vascular blood vessel cell and the physical properties of its environment influence whether the cell grows, produces specialized products, moves, or dies. Through these efforts, Ingber has made pioneering contributions to the fields of angiogenesis, tissue engineering, mechanobiology, and systems biology. His work on how blood vessels form also led to the development of TNP-470, one of the first angiogenesis inhibitors to enter clinical trials.

Ingber's Egg Analogy

How wounds heal and tumors form

Don Ingber, MD, PhD, of the Vascular Biology Program of Boston Children's Hospital and Professor at Harvard Medical School, often uses simple analogies in his lectures to explain how tissues form and how diseases develop. Here is an example.

Our bodies have an incredible ability to heal when we are injured and to keep us healthy. But how does this work? Why do we get scars sometimes and not other times? Why do tumors form in certain tissues, and why are some tumors cancerous while others are not? This explanation uses eggs in a carton to illustrate how cells in our tissues behave during wound healing and tumor formation.

Research Background

Dr. Ingber simultaneously received his MD and PhD from Yale University. He was the Anna Fuller Research Fellow at Children's Hospital Boston and Harvard Medical School.

He is credited on over 20 patents which cover technologies ranging from new cancer drugs and drug-screening assays to medical devices, micromanufacturing techniques, and computer software.

Dr. Ingber is also the founding director of the Wyss Institute for Biologically Inspired Engineering.

Selected Publications

  1. Wang N, Butler JP, Ingber DE. Mechanotransduction across the cell surface and through the cytoskeleton. Science 1993; 260: 1124-1127.
  2. Chen CS, Mrksich M, Huang S, Whitesides G, Ingber DE. Geometric control of cell life and death. Science 1997; 276: 1425-1428.
  3. Ingber, DE. The Architecture of Life. Scientific American Jan 1998; 278: 48-57.

Publications

  1. Biology-inspired dynamic microphysiological system approaches to revolutionize basic research, healthcare and animal welfare. ALTEX. 2025 Jan 17. View Abstract
  2. Inflammatory Bowel Disease Drivers Revealed in Human Organ Chips. medRxiv. 2024 Dec 08. View Abstract
  3. Identification of pharmacological inducers of a reversible hypometabolic state for whole organ preservation. Elife. 2024 Sep 24; 13. View Abstract
  4. Intestinal organ chips for disease modelling and personalized medicine. Nat Rev Gastroenterol Hepatol. 2024 Nov; 21(11):751-773. View Abstract
  5. Donepezil Nanoemulsion Induces a Torpor-like State with Reduced Toxicity in Nonhibernating Xenopus laevis Tadpoles. ACS Nano. 2024 Sep 03; 18(35):23991-24003. View Abstract
  6. Organ chips with integrated multifunctional sensors enable continuous metabolic monitoring at controlled oxygen levels. Biosens Bioelectron. 2024 Dec 01; 265:116683. View Abstract
  7. Exacerbation of influenza virus induced lung injury by alveolar macrophages and its suppression by pyroptosis blockade in a human lung alveolus chip. bioRxiv. 2024 Aug 16. View Abstract
  8. Signal amplification by cyclic extension enables high-sensitivity single-cell mass cytometry. Nat Biotechnol. 2024 Jul 29. View Abstract
  9. A streamlined method to generate endothelial cells from human pluripotent stem cells via transient doxycycline-inducible ETV2 activation. Angiogenesis. 2024 Nov; 27(4):779-795. View Abstract
  10. Mucus production, host-microbiome interactions, hormone sensitivity, and innate immune responses modeled in human cervix chips. Nat Commun. 2024 May 29; 15(1):4578. View Abstract
  11. Redox-Modified Nanostructured Electrochemical Surfaces for Continuous Glucose Monitoring in Complex Biological Fluids. Nanomaterials (Basel). 2024 May 03; 14(9). View Abstract
  12. MRC1 and LYVE1 expressing macrophages in vascular beds of GNAQ p.R183Q driven capillary malformations in Sturge Weber syndrome. Acta Neuropathol Commun. 2024 Mar 26; 12(1):47. View Abstract
  13. Mechanical forces amplify TCR mechanotransduction in T cell activation and function. Appl Phys Rev. 2024 Mar; 11(1):011304. View Abstract
  14. Modeling Healthy and Dysbiotic Vaginal Microenvironments in a Human Vagina-on-a-Chip. J Vis Exp. 2024 Feb 16; (204). View Abstract
  15. Micrometer-thick and porous nanocomposite coating for electrochemical sensors with exceptional antifouling and electroconducting properties. Nat Commun. 2024 Feb 08; 15(1):711. View Abstract
  16. Human organ chips for regenerative pharmacology. Pharmacol Res Perspect. 2024 Feb; 12(1):e01159. View Abstract
  17. DNA origami vaccine (DoriVac) nanoparticles improve both humoral and cellular immune responses to infectious diseases. bioRxiv. 2024 Jan 02. View Abstract
  18. Direct therapeutic effect of sulfadoxine-pyrimethamine on nutritional deficiency-induced enteric dysfunction in a human Intestine Chip. EBioMedicine. 2024 Jan; 99:104921. View Abstract
  19. A human lung alveolus-on-a-chip model of acute radiation-induced lung injury. Nat Commun. 2023 10 16; 14(1):6506. View Abstract
  20. Report of the Assay Guidance Workshop on 3-Dimensional Tissue Models for Antiviral Drug Development. J Infect Dis. 2023 10 03; 228(Suppl 5):S337-S354. View Abstract
  21. Concerted epithelial and stromal changes during progression of Barrett's Esophagus to invasive adenocarcinoma exposed by multi-scale, multi-omics analysis. bioRxiv. 2023 Jun 11. View Abstract
  22. Target-agnostic drug prediction integrated with medical record analysis uncovers differential associations of statins with increased survival in COVID-19 patients. PLoS Comput Biol. 2023 05; 19(5):e1011050. View Abstract
  23. Epithelial-Stromal Interactions in Barrett's Esophagus Modeled in Human Organ Chips. Gastro Hep Adv. 2023; 2(5):676-680. View Abstract
  24. From tensegrity to human organs-on-chips: implications for mechanobiology and mechanotherapeutics. Biochem J. 2023 02 27; 480(4):243-257. View Abstract
  25. Author Correction: Performance assessment and economic analysis of a human Liver-Chip for predictive toxicology. Commun Med (Lond). 2023 Feb 02; 3(1):16. View Abstract
  26. Author Correction: Performance assessment and economic analysis of a human Liver-Chip for predictive toxicology. Commun Med (Lond). 2023 Jan 12; 3(1):7. View Abstract
  27. Rapid quantitation of SARS-CoV-2 antibodies in clinical samples with an electrochemical sensor. Biosens Bioelectron. 2023 Mar 01; 223:115037. View Abstract
  28. Performance assessment and economic analysis of a human Liver-Chip for predictive toxicology. Commun Med (Lond). 2022 Dec 06; 2(1):154. View Abstract
  29. Vaginal microbiome-host interactions modeled in a human vagina-on-a-chip. Microbiome. 2022 11 26; 10(1):201. View Abstract
  30. FcMBL magnetic bead-based MALDI-TOF MS rapidly identifies paediatric blood stream infections from positive blood cultures. PLoS One. 2022; 17(11):e0276777. View Abstract
  31. Differential ABC transporter expression during hematopoiesis contributes to neutrophil-biased toxicity of Aurora kinase inhibitors. Nat Commun. 2022 10 12; 13(1):6021. View Abstract
  32. Modeling mucus physiology and pathophysiology in human organs-on-chips. Adv Drug Deliv Rev. 2022 12; 191:114542. View Abstract
  33. Self-assembling short immunostimulatory duplex RNAs with broad-spectrum antiviral activity. Mol Ther Nucleic Acids. 2022 Sep 13; 29:923-940. View Abstract
  34. PIKfyve-specific inhibitors restrict replication of multiple coronaviruses in vitro but not in a murine model of COVID-19. Commun Biol. 2022 08 12; 5(1):808. View Abstract
  35. A lab-on-a-chip for the concurrent electrochemical detection of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodies in saliva and plasma. Nat Biomed Eng. 2022 08; 6(8):968-978. View Abstract
  36. Target-agnostic drug prediction integrated with medical record analysis uncovers differential associations of statins with increased survival in COVID-19 patients. medRxiv. 2022 Jul 22. View Abstract
  37. Nutritional deficiency in an intestine-on-a-chip recapitulates injury hallmarks associated with environmental enteric dysfunction. Nat Biomed Eng. 2022 11; 6(11):1236-1247. View Abstract
  38. Biofabrication of Multiplexed Electrochemical Immunosensors for Simultaneous Detection of Clinical Biomarkers in Complex Fluids. Adv Healthc Mater. 2022 12; 11(24):e2200589. View Abstract
  39. Enhancers of Host Immune Tolerance to Bacterial Infection Discovered Using Linked Computational and Experimental Approaches. Adv Sci (Weinh). 2022 09; 9(26):e2200222. View Abstract
  40. What Can an Organ-on-a-Chip Teach Us About Human Lung Pathophysiology? Physiology (Bethesda). 2022 09 01; 37(5):0. View Abstract
  41. Interdisciplinarity and mechanobiology. iScience. 2022 May 20; 25(5):104187. View Abstract
  42. Establishment of physiologically relevant oxygen gradients in microfluidic organ chips. Lab Chip. 2022 04 12; 22(8):1584-1593. View Abstract
  43. Mechanical control of innate immune responses against viral infection revealed in a human lung alveolus chip. Nat Commun. 2022 04 08; 13(1):1928. View Abstract
  44. Human organs-on-chips for disease modelling, drug development and personalized medicine. Nat Rev Genet. 2022 08; 23(8):467-491. View Abstract
  45. Ectopic Lymphoid Follicle Formation and Human Seasonal Influenza Vaccination Responses Recapitulated in an Organ-on-a-Chip. Adv Sci (Weinh). 2022 05; 9(14):e2103241. View Abstract
  46. Ultrarapid Method for Coating Electrochemical Sensors with Antifouling Conductive Nanomaterials Enables Highly Sensitive Multiplexed Detection in Whole Blood. Adv Healthc Mater. 2022 04; 11(8):e2102244. View Abstract
  47. Establishment of a Modular Anaerobic Human Intestine Chip. Methods Mol Biol. 2022; 2373:69-85. View Abstract
  48. Bioinspired design and optimization for thin film wearable and building cooling systems. Bioinspir Biomim. 2021 12 16; 17(1). View Abstract
  49. Biochemical and Hematologic Reference Intervals for Anesthetized, Female, Juvenile Yorkshire Swine. J Am Assoc Lab Anim Sci. 2022 01 01; 61(1):21-30. View Abstract
  50. Self-assembling short immunostimulatory duplex RNAs with broad spectrum antiviral activity. bioRxiv. 2021 Nov 22. View Abstract
  51. Modeling pulmonary cystic fibrosis in a human lung airway-on-a-chip. J Cyst Fibros. 2022 07; 21(4):606-615. View Abstract
  52. Enteric Coronavirus Infection and Treatment Modeled With an Immunocompetent Human Intestine-On-A-Chip. Front Pharmacol. 2021; 12:718484. View Abstract
  53. Laboratory-Generated DNA Can Cause Anomalous Pathogen Diagnostic Test Results. Microbiol Spectr. 2021 10 31; 9(2):e0031321. View Abstract
  54. Clinically Relevant Influenza Virus Evolution Reconstituted in a Human Lung Airway-on-a-Chip. Microbiol Spectr. 2021 10 31; 9(2):e0025721. View Abstract
  55. Simulating drug concentrations in PDMS microfluidic organ chips. Lab Chip. 2021 09 14; 21(18):3509-3519. View Abstract
  56. Enabling Multiplexed Electrochemical Detection of Biomarkers with High Sensitivity in Complex Biological Samples. Acc Chem Res. 2021 09 21; 54(18):3529-3539. View Abstract
  57. Evidence generation and reproducibility in cell and gene therapy research: A call to action. Mol Ther Methods Clin Dev. 2021 Sep 10; 22:11-14. View Abstract
  58. Mechanosensation Mediates Long-Range Spatial Decision-Making in an Aneural Organism. Adv Mater. 2021 Aug; 33(34):e2008161. View Abstract
  59. Biomaterial vaccines capturing pathogen-associated molecular patterns protect against bacterial infections and septic shock. Nat Biomed Eng. 2022 01; 6(1):8-18. View Abstract
  60. A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics. Nat Biomed Eng. 2021 08; 5(8):815-829. View Abstract
  61. COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets. Nature. 2021 07; 595(7865):107-113. View Abstract
  62. Transferrin receptor targeting by de novo sheet extension. Proc Natl Acad Sci U S A. 2021 04 27; 118(17). View Abstract
  63. Enabling out-of-body experiences for living organs. J Exp Med. 2021 04 05; 218(4). View Abstract
  64. Harnessing Colon Chip Technology to Identify Commensal Bacteria That Promote Host Tolerance to Infection. Front Cell Infect Microbiol. 2021; 11:638014. View Abstract
  65. A single-cell and spatial atlas of autopsy tissues reveals pathology and cellular targets of SARS-CoV-2. bioRxiv. 2021 Feb 25. View Abstract
  66. Anomalous COVID-19 tests hinder researchers. Science. 2021 01 15; 371(6526):244-245. View Abstract
  67. Molecular mapping of transmembrane mechanotransduction through the ß1 integrin-CD98hc-TRPV4 axis. J Cell Sci. 2020 11 02; 133(20). View Abstract
  68. Is it Time for Reviewer 3 to Request Human Organ Chip Experiments Instead of Animal Validation Studies? Adv Sci (Weinh). 2020 Nov; 7(22):2002030. View Abstract
  69. Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients. Nat Commun. 2020 08 26; 11(1):4253. View Abstract
  70. Proteomic and Metabolomic Characterization of Human Neurovascular Unit Cells in Response to Methamphetamine. Adv Biosyst. 2020 09; 4(9):e1900230. View Abstract
  71. Treatment of psoriasis with NFKBIZ siRNA using topical ionic liquid formulations. Sci Adv. 2020 07; 6(30):eabb6049. View Abstract
  72. Human Organs-on-Chips for Virology. Trends Microbiol. 2020 11; 28(11):934-946. View Abstract
  73. Phosphorylation of ACTN4 Leads to Podocyte Vulnerability and Proteinuric Glomerulosclerosis. J Am Soc Nephrol. 2020 07; 31(7):1479-1495. View Abstract
  74. Author Correction: On-chip recapitulation of clinical bone marrow toxicities and patient-specific pathophysiology. Nat Biomed Eng. 2020 Apr; 4(4):477. View Abstract
  75. Biology-inspired microphysiological systems to advance patient benefit and animal welfare in drug development ALTEX. 2020; 37(3):365-394. View Abstract
  76. YAP Regulates Hematopoietic Stem Cell Formation in Response to the Biomechanical Forces of Blood Flow. Dev Cell. 2020 02 24; 52(4):446-460.e5. View Abstract
  77. On-chip recapitulation of clinical bone marrow toxicities and patient-specific pathophysiology. Nat Biomed Eng. 2020 04; 4(4):394-406. View Abstract
  78. Robotic fluidic coupling and interrogation of multiple vascularized organ chips. Nat Biomed Eng. 2020 04; 4(4):407-420. View Abstract
  79. Quantitative prediction of human pharmacokinetic responses to drugs via fluidically coupled vascularized organ chips. Nat Biomed Eng. 2020 04; 4(4):421-436. View Abstract
  80. Biomimetic smoking robot for in vitro inhalation exposure compatible with microfluidic organ chips. Nat Protoc. 2020 02; 15(2):183-206. View Abstract
  81. AAV-mediated gene therapy targeting TRPV4 mechanotransduction for inhibition of pulmonary vascular leakage. APL Bioeng. 2019 Dec; 3(4):046103. View Abstract
  82. Human Colon-on-a-Chip Enables Continuous In Vitro Analysis of Colon Mucus Layer Accumulation and Physiology. Cell Mol Gastroenterol Hepatol. 2020; 9(3):507-526. View Abstract
  83. An antifouling coating that enables affinity-based electrochemical biosensing in complex biological fluids. Nat Nanotechnol. 2019 12; 14(12):1143-1149. View Abstract
  84. Reproducing human and cross-species drug toxicities using a Liver-Chip. Sci Transl Med. 2019 11 06; 11(517). View Abstract
  85. Tumor-Derived Extracellular Vesicles Breach the Intact Blood-Brain Barrier via Transcytosis. ACS Nano. 2019 12 24; 13(12):13853-13865. View Abstract
  86. Controllable Fabrication of Inhomogeneous Microcapsules for Triggered Release by Osmotic Pressure. Small. 2019 10; 15(42):e1903087. View Abstract
  87. Author Correction: A complex human gut microbiome cultured in an anaerobic intestine-on-a-chip. Nat Biomed Eng. 2019 Jul; 3(7):583. View Abstract
  88. Cellular nanoscale stiffness patterns governed by intracellular forces. Nat Mater. 2019 10; 18(10):1071-1077. View Abstract
  89. Hypoxia-enhanced Blood-Brain Barrier Chip recapitulates human barrier function and shuttling of drugs and antibodies. Nat Commun. 2019 06 13; 10(1):2621. View Abstract
  90. A complex human gut microbiome cultured in an anaerobic intestine-on-a-chip. Nat Biomed Eng. 2019 07; 3(7):520-531. View Abstract
  91. Human Intestinal Morphogenesis Controlled by Transepithelial Morphogen Gradient and Flow-Dependent Physical Cues in a Microengineered Gut-on-a-Chip. iScience. 2019 May 31; 15:391-406. View Abstract
  92. Seeing Your Way to New Insights in Biology. J Mol Biol. 2019 06 28; 431(14):2485-2486. View Abstract
  93. Species-specific enhancement of enterohemorrhagic E. coli pathogenesis mediated by microbiome metabolites. Microbiome. 2019 03 20; 7(1):43. View Abstract
  94. Platelet decoys inhibit thrombosis and prevent metastatic tumor formation in preclinical models. Sci Transl Med. 2019 02 13; 11(479). View Abstract
  95. Modelling cancer in microfluidic human organs-on-chips. Nat Rev Cancer. 2019 02; 19(2):65-81. View Abstract
  96. Non-invasive sensing of transepithelial barrier function and tissue differentiation in organs-on-chips using impedance spectroscopy. Lab Chip. 2019 01 29; 19(3):452-463. View Abstract
  97. Broad-spectrum capture of clinical pathogens using engineered Fc-mannose-binding lectin enhanced by antibiotic treatment. F1000Res. 2019; 8:108. View Abstract
  98. Rapid Coating Process Generates Omniphobic Dentures in Minutes to Reduce C. albicans Biofouling. ACS Biomater Sci Eng. 2019 Feb 11; 5(2):420-424. View Abstract
  99. Scalable Fabrication of Stretchable, Dual Channel, Microfluidic Organ Chips. J Vis Exp. 2018 10 20; (140). View Abstract
  100. From mechanobiology to developmentally inspired engineering. Philos Trans R Soc Lond B Biol Sci. 2018 09 24; 373(1759). View Abstract
  101. Collective Shape Actuation of Polymer Double Emulsions by Solvent Evaporation. ACS Appl Mater Interfaces. 2018 Sep 26; 10(38):31865-31869. View Abstract
  102. A linked organ-on-chip model of the human neurovascular unit reveals the metabolic coupling of endothelial and neuronal cells. Nat Biotechnol. 2018 10; 36(9):865-874. View Abstract
  103. Directed differentiation of human induced pluripotent stem cells into mature kidney podocytes and establishment of a Glomerulus Chip. Nat Protoc. 2018 07; 13(7):1662-1685. View Abstract
  104. Human Organ Chip Models Recapitulate Orthotopic Lung Cancer Growth, Therapeutic Responses, and Tumor Dormancy In Vitro. Cell Rep. 2018 Jun 19; 23(12):3698. View Abstract
  105. Modulation of the Cellular Uptake of DNA Origami through Control over Mass and Shape. Nano Lett. 2018 06 13; 18(6):3557-3564. View Abstract
  106. Developmentally inspired human 'organs on chips'. Development. 2018 05 18; 145(16). View Abstract
  107. Organ-on-Chip Recapitulates Thrombosis Induced by an anti-CD154 Monoclonal Antibody: Translational Potential of Advanced Microengineered Systems. Clin Pharmacol Ther. 2018 12; 104(6):1240-1248. View Abstract
  108. Microfluidic Organ-on-a-Chip Models of Human Intestine. Cell Mol Gastroenterol Hepatol. 2018; 5(4):659-668. View Abstract
  109. Modeling radiation injury-induced cell death and countermeasure drug responses in a human Gut-on-a-Chip. Cell Death Dis. 2018 02 14; 9(2):223. View Abstract
  110. Development of a primary human Small Intestine-on-a-Chip using biopsy-derived organoids. Sci Rep. 2018 02 13; 8(1):2871. View Abstract
  111. PAR1 agonists stimulate APC-like endothelial cytoprotection and confer resistance to thromboinflammatory injury. Proc Natl Acad Sci U S A. 2018 01 30; 115(5):E982-E991. View Abstract
  112. Physiologically Based Pharmacokinetic and Pharmacodynamic Analysis Enabled by Microfluidically Linked Organs-on-Chips. Annu Rev Pharmacol Toxicol. 2018 01 06; 58:37-64. View Abstract
  113. Rapid Prototyping of Thermoplastic Microfluidic Devices. Methods Mol Biol. 2018; 1771:161-170. View Abstract
  114. Art Advancing Science: Filmmaking Leads to Molecular Insights at the Nanoscale. ACS Nano. 2017 12 26; 11(12):12156-12166. View Abstract
  115. A Biologically Inspired, Functionally Graded End Effector for Soft Robotics Applications. Soft Robot. 2017 Dec; 4(4):317-323. View Abstract
  116. Human Organ Chip Models Recapitulate Orthotopic Lung Cancer Growth, Therapeutic Responses, and Tumor Dormancy In Vitro. Cell Rep. 2017 Oct 10; 21(2):508-516. View Abstract
  117. The Wyss institute: A new model for medical technology innovation and translation across the academic-industrial interface. Bioeng Transl Med. 2017 09; 2(3):247-257. View Abstract
  118. Mechanical induction of dentin-like differentiation by adult mouse bone marrow stromal cells using compressive scaffolds. Stem Cell Res. 2017 10; 24:55-60. View Abstract
  119. Primary Human Lung Alveolus-on-a-chip Model of Intravascular Thrombosis for Assessment of Therapeutics. Clin Pharmacol Ther. 2018 02; 103(2):332-340. View Abstract
  120. Organs-on-chips with integrated electrodes for trans-epithelial electrical resistance (TEER) measurements of human epithelial barrier function. Lab Chip. 2017 06 27; 17(13):2264-2271. View Abstract
  121. Organs-on-Chips with combined multi-electrode array and transepithelial electrical resistance measurement capabilities. Lab Chip. 2017 06 27; 17(13):2294-2302. View Abstract
  122. An Engineered Human Fc-Mannose-Binding-Lectin Captures Circulating Tumor Cells. Adv Biosyst. 2017 Jul; 1(7):e1700094. View Abstract
  123. Ultrasound-sensitive nanoparticle aggregates for targeted drug delivery. Biomaterials. 2017 Sep; 139:187-194. View Abstract
  124. Reproductive endocrinology: Cycling through the menstrual cycle - an out-of-body experience. Nat Rev Endocrinol. 2017 07; 13(7):380-382. View Abstract
  125. Mature induced-pluripotent-stem-cell-derived human podocytes reconstitute kidney glomerular-capillary-wall function on a chip. Nat Biomed Eng. 2017; 1. View Abstract
  126. New anticoagulant coatings and hemostasis assessment tools to avoid complications with pediatric left ventricular assist devices. J Thorac Cardiovasc Surg. 2017 10; 154(4):1364-1366. View Abstract
  127. Theory and associated phenomenology for intrinsic mortality arising from natural selection. PLoS One. 2017; 12(3):e0173677. View Abstract
  128. Human Gut-On-A-Chip Supports Polarized Infection of Coxsackie B1 Virus In Vitro. PLoS One. 2017; 12(2):e0169412. View Abstract
  129. Human Lung Small Airway-on-a-Chip Protocol. Methods Mol Biol. 2017; 1612:345-365. View Abstract
  130. Direct Bonding of Chitosan Biomaterials to Tissues Using Transglutaminase for Surgical Repair or Device Implantation. Tissue Eng Part A. 2017 02; 23(3-4):135-142. View Abstract
  131. Commendation for Exposing Key Advantage of Organ Chip Approach. Cell Syst. 2016 11 23; 3(5):411. View Abstract
  132. Matched-Comparative Modeling of Normal and Diseased Human Airway Responses Using a Microengineered Breathing Lung Chip. Cell Syst. 2016 11 23; 3(5):456-466.e4. View Abstract
  133. Co-culture of Living Microbiome with Microengineered Human Intestinal Villi in a Gut-on-a-Chip Microfluidic Device. J Vis Exp. 2016 Aug 30; (114). View Abstract
  134. Assessment of whole blood thrombosis in a microfluidic device lined by fixed human endothelium. Biomed Microdevices. 2016 08; 18(4):73. View Abstract
  135. A Broad-Spectrum Infection Diagnostic that Detects Pathogen-Associated Molecular Patterns (PAMPs) in Whole Blood. EBioMedicine. 2016 Jul; 9:217-227. View Abstract
  136. Rapid Isolation of Staphylococcus aureus Pathogens from Infected Clinical Samples Using Magnetic Beads Coated with Fc-Mannose Binding Lectin. PLoS One. 2016; 11(6):e0156287. View Abstract
  137. Modeling Hematopoiesis and Responses to Radiation Countermeasures in a Bone Marrow-on-a-Chip. Tissue Eng Part C Methods. 2016 05; 22(5):509-15. View Abstract
  138. Reverse Engineering Human Pathophysiology with Organs-on-Chips. Cell. 2016 Mar 10; 164(6):1105-1109. View Abstract
  139. Distinct Contributions of Astrocytes and Pericytes to Neuroinflammation Identified in a 3D Human Blood-Brain Barrier on a Chip. PLoS One. 2016; 11(3):e0150360. View Abstract
  140. Purified and Recombinant Hemopexin: Protease Activity and Effect on Neutrophil Chemotaxis. Mol Med. 2016 Sep; 22:22-31. View Abstract
  141. A shear gradient-activated microfluidic device for automated monitoring of whole blood haemostasis and platelet function. Nat Commun. 2016 Jan 06; 7:10176. View Abstract
  142. Acceleration of Lung Regeneration by Platelet-Rich Plasma Extract through the Low-Density Lipoprotein Receptor-Related Protein 5-Tie2 Pathway. Am J Respir Cell Mol Biol. 2016 Jan; 54(1):103-13. View Abstract
  143. Small airway-on-a-chip enables analysis of human lung inflammation and drug responses in vitro. Nat Methods. 2016 Feb; 13(2):151-7. View Abstract
  144. Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip. Proc Natl Acad Sci U S A. 2016 Jan 05; 113(1):E7-15. View Abstract
  145. Shear-Activated Nanoparticle Aggregates Combined With Temporary Endovascular Bypass to Treat Large Vessel Occlusion. Stroke. 2015 Dec; 46(12):3507-13. View Abstract
  146. Optimization of Pathogen Capture in Flowing Fluids with Magnetic Nanoparticles. Small. 2015 Nov 11; 11(42):5657-66. View Abstract
  147. Matrix elasticity of void-forming hydrogels controls transplanted-stem-cell-mediated bone formation. Nat Mater. 2015 Dec; 14(12):1269-77. View Abstract
  148. Improved treatment of systemic blood infections using antibiotics with extracorporeal opsonin hemoadsorption. Biomaterials. 2015 Oct; 67:382-92. View Abstract
  149. Control of cancer formation by intrinsic genetic noise and microenvironmental cues. Nat Rev Cancer. 2015 Aug; 15(8):499-509. View Abstract
  150. Programed Death is Favored by Natural Selection in Spatial Systems. Phys Rev Lett. 2015 Jun 12; 114(23):238103. View Abstract
  151. Mesenchymal condensation-dependent accumulation of collagen VI stabilizes organ-specific cell fates during embryonic tooth formation. Dev Dyn. 2015 Jun; 244(6):713-23. View Abstract
  152. Biomechanical forces promote blood development through prostaglandin E2 and the cAMP-PKA signaling axis. J Exp Med. 2015 May 04; 212(5):665-80. View Abstract
  153. Activation of mechanosensitive ion channel TRPV4 normalizes tumor vasculature and improves cancer therapy. Oncogene. 2016 Jan 21; 35(3):314-22. View Abstract
  154. Measuring direct current trans-epithelial electrical resistance in organ-on-a-chip microsystems. Lab Chip. 2015 Feb 07; 15(3):745-52. View Abstract
  155. Generation of biocompatible droplets for in vivo and in vitro measurement of cell-generated mechanical stresses. Methods Cell Biol. 2015; 125:373-90. View Abstract
  156. Targeted drug delivery to flow-obstructed blood vessels using mechanically activated nanotherapeutics. JAMA Neurol. 2015 Jan; 72(1):119-22. View Abstract
  157. Engineered in vitro disease models. Annu Rev Pathol. 2015; 10:195-262. View Abstract
  158. A bioinspired omniphobic surface coating on medical devices prevents thrombosis and biofouling. Nat Biotechnol. 2014 Nov; 32(11):1134-40. View Abstract
  159. An extracorporeal blood-cleansing device for sepsis therapy. Nat Med. 2014 Oct; 20(10):1211-6. View Abstract
  160. Mononuclear cells from dedifferentiation of mouse myotubes display remarkable regenerative capability. Stem Cells. 2014 Sep; 32(9):2492-501. View Abstract
  161. Microfluidic organs-on-chips. Nat Biotechnol. 2014 Aug; 32(8):760-72. View Abstract
  162. Stationary nanoliter droplet array with a substrate of choice for single adherent/nonadherent cell incubation and analysis. Proc Natl Acad Sci U S A. 2014 Aug 05; 111(31):11293-8. View Abstract
  163. Nanoparticle targeting of anti-cancer drugs that alter intracellular signaling or influence the tumor microenvironment. Adv Drug Deliv Rev. 2014 Dec 15; 79-80:107-18. View Abstract
  164. Bone marrow-on-a-chip replicates hematopoietic niche physiology in vitro. Nat Methods. 2014 Jun; 11(6):663-9. View Abstract
  165. Interview with Donald E Ingber. Nanomedicine (Lond). 2014 May; 9(7):949-54. View Abstract
  166. Tensegrity, cellular biophysics, and the mechanics of living systems. Rep Prog Phys. 2014 Apr; 77(4):046603. View Abstract
  167. Developmentally-inspired shrink-wrap polymers for mechanical induction of tissue differentiation. Adv Mater. 2014 May 28; 26(20):3253-7. View Abstract
  168. Paxillin controls endothelial cell migration and tumor angiogenesis by altering neuropilin 2 expression. J Cell Sci. 2014 Apr 15; 127(Pt 8):1672-83. View Abstract
  169. Mechanotransduction of fluid stresses governs 3D cell migration. Proc Natl Acad Sci U S A. 2014 Feb 18; 111(7):2447-52. View Abstract
  170. A combinatorial cell-laden gel microarray for inducing osteogenic differentiation of human mesenchymal stem cells. Sci Rep. 2014 Jan 29; 4:3896. View Abstract
  171. A microdevice for rapid optical detection of magnetically captured rare blood pathogens. Lab Chip. 2014 Jan 07; 14(1):182-8. View Abstract
  172. Silencing HoxA1 by intraductal injection of siRNA lipidoid nanoparticles prevents mammary tumor progression in mice. Sci Transl Med. 2014 Jan 01; 6(217):217ra2. View Abstract
  173. Developing microphysiological systems for use as regulatory tools--challenges and opportunities. ALTEX. 2014; 31(3):364-7. View Abstract
  174. Quantifying cell-generated mechanical forces within living embryonic tissues. Nat Methods. 2014 Feb; 11(2):183-9. View Abstract
  175. Reply: To PMID 23711562. Neonatology. 2014; 105(1):26. View Abstract
  176. Microfabrication of human organs-on-chips. Nat Protoc. 2013 Nov; 8(11):2135-57. View Abstract
  177. Clear castable polyurethane elastomer for fabrication of microfluidic devices. Lab Chip. 2013 Oct 07; 13(19):3956-64. View Abstract
  178. Intraductal injection for localized drug delivery to the mouse mammary gland. J Vis Exp. 2013 Oct 04; (80). View Abstract
  179. How changes in extracellular matrix mechanics and gene expression variability might combine to drive cancer progression. PLoS One. 2013; 8(10):e76122. View Abstract
  180. Organs on Chips 2013. Lab Chip. 2013 Sep 21; 13(18):3447-8. View Abstract
  181. Gut-on-a-Chip microenvironment induces human intestinal cells to undergo villus differentiation. Integr Biol (Camb). 2013 Sep; 5(9):1130-40. View Abstract
  182. Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment. Integr Biol (Camb). 2013 Sep; 5(9):1119-29. View Abstract
  183. Platform for high-throughput testing of the effect of soluble compounds on 3D cell cultures. Anal Chem. 2013 Sep 03; 85(17):8085-94. View Abstract
  184. Breast cancer normalization induced by embryonic mesenchyme is mediated by extracellular matrix biglycan. Integr Biol (Camb). 2013 Aug; 5(8):1045-56. View Abstract
  185. Epoxyeicosanoids promote organ and tissue regeneration. Proc Natl Acad Sci U S A. 2013 Aug 13; 110(33):13528-33. View Abstract
  186. SLLISWD sequence in the 10FNIII domain initiates fibronectin fibrillogenesis. J Biol Chem. 2013 Jul 19; 288(29):21329-21340. View Abstract
  187. Low urine vascular endothelial growth factor levels are associated with mechanical ventilation, bronchopulmonary dysplasia and retinopathy of prematurity. Neonatology. 2013; 104(1):56-64. View Abstract
  188. Nogo-A is a negative regulator of CNS angiogenesis. Proc Natl Acad Sci U S A. 2013 May 21; 110(21):E1943-52. View Abstract
  189. Control of lung vascular permeability and endotoxin-induced pulmonary oedema by changes in extracellular matrix mechanics. Nat Commun. 2013; 4:1759. View Abstract
  190. Mechanobiology and developmental control. Annu Rev Cell Dev Biol. 2013; 29:27-61. View Abstract
  191. A human disease model of drug toxicity-induced pulmonary edema in a lung-on-a-chip microdevice. Sci Transl Med. 2012 Nov 07; 4(159):159ra147. View Abstract
  192. A mini-microscope for in situ monitoring of cells. Lab Chip. 2012 Oct 21; 12(20):3976-82. View Abstract
  193. Paxillin controls directional cell motility in response to physical cues. Cell Adh Migr. 2012 Nov-Dec; 6(6):502-8. View Abstract
  194. LRP5 regulates development of lung microvessels and alveoli through the angiopoietin-Tie2 pathway. PLoS One. 2012; 7(7):e41596. View Abstract
  195. Shear-activated nanotherapeutics for drug targeting to obstructed blood vessels. Science. 2012 Aug 10; 337(6095):738-42. View Abstract
  196. Mechanosensitive mechanisms in transcriptional regulation. J Cell Sci. 2012 Jul 01; 125(Pt 13):3061-73. View Abstract
  197. Lab on a chip: United States of America. Lab Chip. 2012 Jun 21; 12(12):2089-90. View Abstract
  198. Inhibition of mammary tumor growth using lysyl oxidase-targeting nanoparticles to modify extracellular matrix. Nano Lett. 2012 Jun 13; 12(6):3213-7. View Abstract
  199. Microengineered physiological biomimicry: organs-on-chips. Lab Chip. 2012 Jun 21; 12(12):2156-64. View Abstract
  200. A combined micromagnetic-microfluidic device for rapid capture and culture of rare circulating tumor cells. Lab Chip. 2012 Jun 21; 12(12):2175-81. View Abstract
  201. Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow. Lab Chip. 2012 Jun 21; 12(12):2165-74. View Abstract
  202. A Wnt-bmp feedback circuit controls intertissue signaling dynamics in tooth organogenesis. Sci Signal. 2012 Jan 10; 5(206):ra4. View Abstract
  203. Polymeric nanomaterials for islet targeting and immunotherapeutic delivery. Nano Lett. 2012 Jan 11; 12(1):203-8. View Abstract
  204. Forty-year journey of angiogenesis translational research. Sci Transl Med. 2011 Dec 21; 3(114):114rv3. View Abstract
  205. Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice. J Clin Invest. 2012 Jan; 122(1):178-91. View Abstract
  206. Paxillin mediates sensing of physical cues and regulates directional cell motility by controlling lamellipodia positioning. PLoS One. 2011; 6(12):e28303. View Abstract
  207. Unexpected strength and toughness in chitosan-fibroin laminates inspired by insect cuticle. Adv Mater. 2012 Jan 24; 24(4):480-4. View Abstract
  208. From 3D cell culture to organs-on-chips. Trends Cell Biol. 2011 Dec; 21(12):745-54. View Abstract
  209. Mechanochemical control of mesenchymal condensation and embryonic tooth organ formation. Dev Cell. 2011 Oct 18; 21(4):758-69. View Abstract
  210. The Wyss Institute at Harvard University. IEEE Pulse. 2011 Jul-Aug; 2(4):43-6. View Abstract
  211. Multizone paper platform for 3D cell cultures. PLoS One. 2011 May 06; 6(5):e18940. View Abstract
  212. Filamin A regulates focal adhesion disassembly and suppresses breast cancer cell migration and invasion. J Exp Med. 2010 Oct 25; 207(11):2421-37. View Abstract
  213. Ultra-rapid activation of TRPV4 ion channels by mechanical forces applied to cell surface beta1 integrins. Integr Biol (Camb). 2010 Sep; 2(9):435-42. View Abstract
  214. Reconstituting organ-level lung functions on a chip. Science. 2010 Jun 25; 328(5986):1662-8. View Abstract
  215. Self-assembly of three-dimensional prestressed tensegrity structures from DNA. Nat Nanotechnol. 2010 Jul; 5(7):520-4. View Abstract
  216. Mechanical control of tissue and organ development. Development. 2010 May; 137(9):1407-20. View Abstract
  217. From cellular mechanotransduction to biologically inspired engineering: 2009 Pritzker Award Lecture, BMES Annual Meeting October 10, 2009. Ann Biomed Eng. 2010 Mar; 38(3):1148-61. View Abstract
  218. Carbon metabolism-mediated myogenic differentiation. Nat Chem Biol. 2010 Mar; 6(3):202-204. View Abstract
  219. Tumor growth and angiogenesis are dependent on the presence of immature dendritic cells. FASEB J. 2010 May; 24(5):1411-8. View Abstract
  220. Paper-supported 3D cell culture for tissue-based bioassays. Proc Natl Acad Sci U S A. 2009 Nov 03; 106(44):18457-62. View Abstract
  221. Cytoskeletal control of growth and cell fate switching. Curr Opin Cell Biol. 2009 Dec; 21(6):864-70. View Abstract
  222. Discovery of potent and practical antiangiogenic agents inspired by cortistatin A. J Am Chem Soc. 2009 Jul 01; 131(25):9014-9. View Abstract
  223. TRPV4 channels mediate cyclic strain-induced endothelial cell reorientation through integrin-to-integrin signaling. Circ Res. 2009 May 08; 104(9):1123-30. View Abstract
  224. Biomechanics: cell research and applications for the next decade. Ann Biomed Eng. 2009 May; 37(5):847-59. View Abstract
  225. Mechanical control of cAMP signaling through integrins is mediated by the heterotrimeric Galphas protein. J Cell Biochem. 2009 Mar 01; 106(4):529-38. View Abstract
  226. A mechanosensitive transcriptional mechanism that controls angiogenesis. Nature. 2009 Feb 26; 457(7233):1103-8. View Abstract
  227. Micromagnetic-microfluidic blood cleansing device. Lab Chip. 2009 May 07; 9(9):1171-7. View Abstract
  228. Using self-assembled monolayers to pattern ECM proteins and cells on substrates. Methods Mol Biol. 2009; 522:183-94. View Abstract
  229. Mechanotransduction at a distance: mechanically coupling the extracellular matrix with the nucleus. Nat Rev Mol Cell Biol. 2009 Jan; 10(1):75-82. View Abstract
  230. Noise-driven stem cell and progenitor population dynamics. PLoS One. 2008 Aug 13; 3(8):e2922. View Abstract
  231. Tumor-derived endothelial cells exhibit aberrant Rho-mediated mechanosensing and abnormal angiogenesis in vitro. Proc Natl Acad Sci U S A. 2008 Aug 12; 105(32):11305-10. View Abstract
  232. ABL2/ARG tyrosine kinase mediates SEMA3F-induced RhoA inactivation and cytoskeleton collapse in human glioma cells. J Biol Chem. 2008 Oct 03; 283(40):27230-8. View Abstract
  233. A multi-modular tensegrity model of an actin stress fiber. J Biomech. 2008 Aug 07; 41(11):2379-87. View Abstract
  234. Tensegrity and mechanotransduction. J Bodyw Mov Ther. 2008 Jul; 12(3):198-200. View Abstract
  235. Fibronectin unfolding revisited: modeling cell traction-mediated unfolding of the tenth type-III repeat. PLoS One. 2008; 3(6):e2373. View Abstract
  236. Transcriptome-wide noise controls lineage choice in mammalian progenitor cells. Nature. 2008 May 22; 453(7194):544-7. View Abstract
  237. Rho signaling and mechanical control of vascular development. Curr Opin Hematol. 2008 May; 15(3):228-34. View Abstract
  238. Absence of cyclooxygenase-2 exacerbates hypoxia-induced pulmonary hypertension and enhances contractility of vascular smooth muscle cells. Circulation. 2008 Apr 22; 117(16):2114-22. View Abstract
  239. Can cancer be reversed by engineering the tumor microenvironment? Semin Cancer Biol. 2008 Oct; 18(5):356-64. View Abstract
  240. Investigating complexity of protein-protein interactions in focal adhesions. Biochem Biophys Res Commun. 2008 May 09; 369(3):929-34. View Abstract
  241. Endothelial cilia are fluid shear sensors that regulate calcium signaling and nitric oxide production through polycystin-1. Circulation. 2008 Mar 04; 117(9):1161-71. View Abstract
  242. Tensegrity-based mechanosensing from macro to micro. Prog Biophys Mol Biol. 2008 Jun-Jul; 97(2-3):163-79. View Abstract
  243. Directional control of cell motility through focal adhesion positioning and spatial control of Rac activation. FASEB J. 2008 Jun; 22(6):1649-59. View Abstract
  244. Methods for studying mechanical control of angiogenesis by the cytoskeleton and extracellular matrix. Methods Enzymol. 2008; 443:227-59. View Abstract
  245. Nanomagnetic actuation of receptor-mediated signal transduction. Nat Nanotechnol. 2008 Jan; 3(1):36-40. View Abstract
  246. Synaptic reorganization in scaled networks of controlled size. J Neurosci. 2007 Dec 12; 27(50):13581-9. View Abstract
  247. Tensile forces stimulate vascular remodeling and epidermal cell proliferation in living skin. Ann Surg. 2007 Nov; 246(5):896-902. View Abstract
  248. Extracellular matrix, mechanotransduction and structural hierarchies in heart tissue engineering. Philos Trans R Soc Lond B Biol Sci. 2007 Aug 29; 362(1484):1267-79. View Abstract
  249. Micromechanical control of cell and tissue development: implications for tissue engineering. Adv Drug Deliv Rev. 2007 Nov 10; 59(13):1306-18. View Abstract
  250. Rheological behavior of living cells is timescale-dependent. Biophys J. 2007 Oct 15; 93(8):L39-41. View Abstract
  251. Angiopoietin-1 requires p190 RhoGAP to protect against vascular leakage in vivo. J Biol Chem. 2007 Aug 17; 282(33):23910-8. View Abstract
  252. What lies at the interface of regenerative medicine and developmental biology? Development. 2007 Jul; 134(14):2541-7. View Abstract
  253. The May-Hegglin anomaly gene MYH9 is a negative regulator of platelet biogenesis modulated by the Rho-ROCK pathway. Blood. 2007 Jul 01; 110(1):171-9. View Abstract
  254. Nanostructured magnetizable materials that switch cells between life and death. Biomaterials. 2007 Jun; 28(17):2783-90. View Abstract
  255. Filamin links cell shape and cytoskeletal structure to Rho regulation by controlling accumulation of p190RhoGAP in lipid rafts. J Cell Sci. 2007 Feb 01; 120(Pt 3):456-67. View Abstract
  256. Tools to study cell mechanics and mechanotransduction. Methods Cell Biol. 2007; 83:443-72. View Abstract
  257. Tissue engineering and developmental biology: going biomimetic. Tissue Eng. 2006 Dec; 12(12):3265-83. View Abstract
  258. Combined microfluidic-micromagnetic separation of living cells in continuous flow. Biomed Microdevices. 2006 Dec; 8(4):299-308. View Abstract
  259. Methods for measuring rates of protein binding to insoluble scaffolds in living cells: histone H1-chromatin interactions. J Cell Biochem. 2006 Dec 01; 99(5):1334-42. View Abstract
  260. Alpha-actinin-4 is required for normal podocyte adhesion. J Biol Chem. 2007 Jan 05; 282(1):467-77. View Abstract
  261. Magnetically-guided self-assembly of fibrin matrices with ordered nano-scale structure for tissue engineering. Tissue Eng. 2006 Nov; 12(11):3247-56. View Abstract
  262. Estrogen-receptor-alpha exchange and chromatin dynamics are ligand- and domain-dependent. J Cell Sci. 2006 Oct 01; 119(Pt 19):4101-16. View Abstract
  263. l-Caldesmon regulates proliferation and migration of vascular smooth muscle cells and inhibits neointimal formation after angioplasty. Arterioscler Thromb Vasc Biol. 2006 Oct; 26(10):2231-7. View Abstract
  264. Microtubules can bear enhanced compressive loads in living cells because of lateral reinforcement. J Cell Biol. 2006 Jun 05; 173(5):733-41. View Abstract
  265. Cellular mechanotransduction: putting all the pieces together again. FASEB J. 2006 May; 20(7):811-27. View Abstract
  266. Force meets chemistry: analysis of mechanochemical conversion in focal adhesions using fluorescence recovery after photobleaching. J Cell Biochem. 2006 Apr 15; 97(6):1175-83. View Abstract
  267. Loss of polycystin-1 in human cyst-lining epithelia leads to ciliary dysfunction. J Am Soc Nephrol. 2006 Apr; 17(4):1015-25. View Abstract
  268. Mechanical forces alter zyxin unbinding kinetics within focal adhesions of living cells. J Cell Physiol. 2006 Apr; 207(1):187-94. View Abstract
  269. Multistable and multistep dynamics in neutrophil differentiation. BMC Cell Biol. 2006 Feb 28; 7:11. View Abstract
  270. Viscoelastic retraction of single living stress fibers and its impact on cell shape, cytoskeletal organization, and extracellular matrix mechanics. Biophys J. 2006 May 15; 90(10):3762-73. View Abstract
  271. Cellular adaptation to mechanical stress: role of integrins, Rho, cytoskeletal tension and mechanosensitive ion channels. J Cell Sci. 2006 Feb 01; 119(Pt 3):508-18. View Abstract
  272. Mechanical control of tissue morphogenesis during embryological development. Int J Dev Biol. 2006; 50(2-3):255-66. View Abstract
  273. A non-genetic basis for cancer progression and metastasis: self-organizing attractors in cell regulatory networks. Breast Dis. 2006-2007; 26:27-54. View Abstract
  274. Towards a holistic, yet gene-centered analysis of gene expression profiles: a case study of human lung cancers. J Biomed Biotechnol. 2006; 2006(5):69141. View Abstract
  275. Alpha4beta1-dependent adhesion strengthening under mechanical strain is regulated by paxillin association with the alpha4-cytoplasmic domain. J Cell Biol. 2005 Dec 19; 171(6):1073-84. View Abstract
  276. Evidence by molecular profiling for a placental origin of infantile hemangioma. Proc Natl Acad Sci U S A. 2005 Dec 27; 102(52):19097-102. View Abstract
  277. A mathematical model to determine molecular kinetic rate constants under non-steady state conditions using fluorescence recovery after photobleaching (FRAP). Biophys Chem. 2006 Mar 01; 120(1):32-5. View Abstract
  278. Integrins beta1, alpha6, and alpha3 contribute to mechanical strain-induced differentiation of fetal lung type II epithelial cells via distinct mechanisms. Am J Physiol Lung Cell Mol Physiol. 2006 Feb; 290(2):L343-50. View Abstract
  279. Cell tension, matrix mechanics, and cancer development. Cancer Cell. 2005 Sep; 8(3):175-6. View Abstract
  280. Control of the direction of lamellipodia extension through changes in the balance between Rac and Rho activities. Mol Cell Biomech. 2005 Sep; 2(3):135-43. View Abstract
  281. Mechanical control of tissue growth: function follows form. Proc Natl Acad Sci U S A. 2005 Aug 16; 102(33):11571-2. View Abstract
  282. Symmetry-breaking in mammalian cell cohort migration during tissue pattern formation: role of random-walk persistence. Cell Motil Cytoskeleton. 2005 Aug; 61(4):201-13. View Abstract
  283. Tissue adaptation to mechanical forces in healthy, injured and aging tissues. Scand J Med Sci Sports. 2005 Aug; 15(4):199-201. View Abstract
  284. High-betweenness proteins in the yeast protein interaction network. J Biomed Biotechnol. 2005 Jun 30; 2005(2):96-103. View Abstract
  285. Pulse energy dependence of subcellular dissection by femtosecond laser pulses. Opt Express. 2005 May 16; 13(10):3690-6. View Abstract
  286. Cell fates as high-dimensional attractor states of a complex gene regulatory network. Phys Rev Lett. 2005 Apr 01; 94(12):128701. View Abstract
  287. Novel dynamic rheological behavior of individual focal adhesions measured within single cells using electromagnetic pulling cytometry. Acta Biomater. 2005 May; 1(3):295-303. View Abstract
  288. Inhibition of endothelial cell migration by thrombospondin-1 type-1 repeats is mediated by beta1 integrins. J Cell Biol. 2005 Feb 14; 168(4):643-53. View Abstract
  289. Control of basement membrane remodeling and epithelial branching morphogenesis in embryonic lung by Rho and cytoskeletal tension. Dev Dyn. 2005 Feb; 232(2):268-81. View Abstract
  290. Ablation of cytoskeletal filaments and mitochondria in live cells using a femtosecond laser nanoscissor. Mech Chem Biosyst. 2005; 2(1):17-25. View Abstract
  291. Global cytoskeletal control of mechanotransduction in kidney epithelial cells. Exp Cell Res. 2004 Nov 15; 301(1):23-30. View Abstract
  292. Vacuum-assisted closure: microdeformations of wounds and cell proliferation. Plast Reconstr Surg. 2004 Oct; 114(5):1086-96; discussion 1097-8. View Abstract
  293. An improved mathematical approach for determination of molecular kinetics in living cells with FRAP. Mech Chem Biosyst. 2004 Sep; 1(3):181-90. View Abstract
  294. Role of RhoA, mDia, and ROCK in cell shape-dependent control of the Skp2-p27kip1 pathway and the G1/S transition. J Biol Chem. 2004 Jun 18; 279(25):26323-30. View Abstract
  295. A computational tensegrity model predicts dynamic rheological behaviors in living cells. Ann Biomed Eng. 2004 Apr; 32(4):520-30. View Abstract
  296. Extracellular matrix controls myosin light chain phosphorylation and cell contractility through modulation of cell shape and cytoskeletal prestress. Am J Physiol Cell Physiol. 2004 Mar; 286(3):C518-28. View Abstract
  297. The mechanochemical basis of cell and tissue regulation. Mech Chem Biosyst. 2004 Mar; 1(1):53-68. View Abstract
  298. Mechanical properties of individual focal adhesions probed with a magnetic microneedle. Biochem Biophys Res Commun. 2004 Jan 16; 313(3):758-64. View Abstract
  299. Magnetic Cellular Switches. IEEE Trans Magn. 2004; 40(4):2958-2960. View Abstract
  300. Gene Expression Dynamics Inspector (GEDI): for integrative analysis of expression profiles. Bioinformatics. 2003 Nov 22; 19(17):2321-2. View Abstract
  301. Cell shape provides global control of focal adhesion assembly. Biochem Biophys Res Commun. 2003 Jul 25; 307(2):355-61. View Abstract
  302. Identification of a distinct class of cytoskeleton-associated mRNAs using microarray technology. BMC Cell Biol. 2003 Jul 08; 4:6. View Abstract
  303. Intracellular stress tomography reveals stress focusing and structural anisotropy in cytoskeleton of living cells. Am J Physiol Cell Physiol. 2003 Nov; 285(5):C1082-90. View Abstract
  304. Tensegrity II. How structural networks influence cellular information processing networks. J Cell Sci. 2003 Apr 15; 116(Pt 8):1397-408. View Abstract
  305. Tensegrity I. Cell structure and hierarchical systems biology. J Cell Sci. 2003 Apr 01; 116(Pt 7):1157-73. View Abstract
  306. Geometric determinants of directional cell motility revealed using microcontact printing. Langmuir. 2003 Mar 04; 19(5):1611-7. View Abstract
  307. Mechanosensation through integrins: cells act locally but think globally. Proc Natl Acad Sci U S A. 2003 Feb 18; 100(4):1472-4. View Abstract
  308. Selective chemical treatment of cellular microdomains using multiple laminar streams. Chem Biol. 2003 Feb; 10(2):123-30. View Abstract
  309. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat Genet. 2003 Feb; 33(2):129-37. View Abstract
  310. Caldesmon-dependent switching between capillary endothelial cell growth and apoptosis through modulation of cell shape and contractility. Angiogenesis. 2003; 6(1):55-64. View Abstract
  311. Mechanobiology and diseases of mechanotransduction. Ann Med. 2003; 35(8):564-77. View Abstract
  312. Cancer as a disease of epithelial-mesenchymal interactions and extracellular matrix regulation. Differentiation. 2002 Dec; 70(9-10):547-60. View Abstract
  313. Mechanical signaling and the cellular response to extracellular matrix in angiogenesis and cardiovascular physiology. Circ Res. 2002 Nov 15; 91(10):877-87. View Abstract
  314. Sequential involvement of Cdk1, mTOR and p53 in apoptosis induced by the HIV-1 envelope. EMBO J. 2002 Aug 01; 21(15):4070-80. View Abstract
  315. Directional control of lamellipodia extension by constraining cell shape and orienting cell tractional forces. FASEB J. 2002 Aug; 16(10):1195-204. View Abstract
  316. Mechanical signaling. Ann N Y Acad Sci. 2002 Jun; 961:162-3. View Abstract
  317. Molecular signaling: breakout session summary. Ann N Y Acad Sci. 2002 Jun; 961:164-7. View Abstract
  318. Micropatterning tractional forces in living cells. Cell Motil Cytoskeleton. 2002 Jun; 52(2):97-106. View Abstract
  319. Models of cytoskeletal mechanics of adherent cells. Biomech Model Mechanobiol. 2002 Jun; 1(1):95-108. View Abstract
  320. Control of embryonic lung branching morphogenesis by the Rho activator, cytotoxic necrotizing factor 1. J Surg Res. 2002 May 15; 104(2):95-100. View Abstract
  321. A discrete cell cycle checkpoint in late G(1) that is cytoskeleton-dependent and MAP kinase (Erk)-independent. Exp Cell Res. 2002 May 01; 275(2):255-64. View Abstract
  322. Mechanotransduction: all signals point to cytoskeleton, matrix, and integrins. Sci STKE. 2002 Feb 12; 2002(119):pe6. View Abstract
  323. Intact vinculin protein is required for control of cell shape, cell mechanics, and rac-dependent lamellipodia formation. Biochem Biophys Res Commun. 2002 Jan 18; 290(2):749-55. View Abstract
  324. Use of micropatterned adhesive surfaces for control of cell behavior. Methods Cell Biol. 2002; 69:385-401. View Abstract
  325. Cooperative control of Akt phosphorylation, bcl-2 expression, and apoptosis by cytoskeletal microfilaments and microtubules in capillary endothelial cells. Mol Biol Cell. 2001 Oct; 12(10):3087-94. View Abstract
  326. Mechanical behavior in living cells consistent with the tensegrity model. Proc Natl Acad Sci U S A. 2001 Jul 03; 98(14):7765-70. View Abstract
  327. Subcellular positioning of small molecules. Nature. 2001 Jun 28; 411(6841):1016. View Abstract
  328. Soft lithography in biology and biochemistry. Annu Rev Biomed Eng. 2001; 3:335-73. View Abstract
  329. The origin of cellular life. Bioessays. 2000 Dec; 22(12):1160-70. View Abstract
  330. Shape-dependent control of cell growth, differentiation, and apoptosis: switching between attractors in cell regulatory networks. Exp Cell Res. 2000 Nov 25; 261(1):91-103. View Abstract
  331. Apoptosis of syncytia induced by the HIV-1-envelope glycoprotein complex: influence of cell shape and size. Exp Cell Res. 2000 Nov 25; 261(1):119-26. View Abstract
  332. Adhesion-dependent control of matrix metalloproteinase-2 activation in human capillary endothelial cells. J Cell Sci. 2000 Nov; 113 ( Pt 22):3979-87. View Abstract
  333. Analysis of cell mechanics in single vinculin-deficient cells using a magnetic tweezer. Biochem Biophys Res Commun. 2000 Oct 14; 277(1):93-9. View Abstract
  334. Opposing views on tensegrity as a structural framework for understanding cell mechanics. J Appl Physiol (1985). 2000 Oct; 89(4):1663-70. View Abstract
  335. Symmetry breaking in cultured mammalian cells. In Vitro Cell Dev Biol Anim. 2000 Oct; 36(9):563-5. View Abstract
  336. Mechanical control of cyclic AMP signalling and gene transcription through integrins. Nat Cell Biol. 2000 Sep; 2(9):666-8. View Abstract
  337. Patterned deposition of cells and proteins onto surfaces by using three-dimensional microfluidic systems. Proc Natl Acad Sci U S A. 2000 Mar 14; 97(6):2408-13. View Abstract
  338. Using self-assembled monolayers to pattern ECM proteins and cells on substrates. Methods Mol Biol. 2000; 139:209-19. View Abstract
  339. Patterning proteins and cells using soft lithography. Biomaterials. 1999 Dec; 20(23-24):2363-76. View Abstract
  340. New role for tRNA and its fragment purified from human urinary bladder carcinoma conditioned medium: inhibition of endothelial cell growth. J Cell Biochem. 1999 Nov; 76(1):109-17. View Abstract
  341. The shedding of membrane-anchored heparin-binding epidermal-like growth factor is regulated by the Raf/mitogen-activated protein kinase cascade and by cell adhesion and spreading. J Biol Chem. 1999 Oct 01; 274(40):28828-35. View Abstract
  342. Geometric control of switching between growth, apoptosis, and differentiation during angiogenesis using micropatterned substrates. In Vitro Cell Dev Biol Anim. 1999 Sep; 35(8):441-8. View Abstract
  343. The structural and mechanical complexity of cell-growth control. Nat Cell Biol. 1999 Sep; 1(5):E131-8. View Abstract
  344. Pictures in cell biology: squaring up to the cell-shape debate. Trends Cell Biol. 1999 Jul; 9(7):283. View Abstract
  345. How cells (might) sense microgravity. FASEB J. 1999; 13 Suppl:S3-15. View Abstract
  346. Tensegrity and mechanoregulation: from skeleton to cytoskeleton. Osteoarthritis Cartilage. 1999 Jan; 7(1):81-94. View Abstract
  347. Control of cyclin D1, p27(Kip1), and cell cycle progression in human capillary endothelial cells by cell shape and cytoskeletal tension. Mol Biol Cell. 1998 Nov; 9(11):3179-93. View Abstract
  348. Regulation of cytoskeletal mechanics and cell growth by myosin light chain phosphorylation. Am J Physiol. 1998 11; 275(5):C1349-56. View Abstract
  349. Ionic control of chromosome architecture in living and permeabilized cells. Exp Cell Res. 1998 Oct 10; 244(1):286-94. View Abstract
  350. Impaired mechanical stability, migration and contractile capacity in vimentin-deficient fibroblasts. J Cell Sci. 1998 Jul; 111 ( Pt 13):1897-907. View Abstract
  351. Cellular basis of mechanotransduction. Biol Bull. 1998 Jun; 194(3):323-5; discussion 325-7. View Abstract
  352. DNA topoisomerase II can drive changes in higher order chromosome architecture without enzymatically modifying DNA. J Cell Biochem. 1998 May 01; 69(2):127-42. View Abstract
  353. Is cytoskeletal tension a major determinant of cell deformability in adherent endothelial cells? Am J Physiol. 1998 05; 274(5):C1283-9. View Abstract
  354. Micropatterned surfaces for control of cell shape, position, and function. Biotechnol Prog. 1998 May-Jun; 14(3):356-63. View Abstract
  355. Integrin binding and mechanical tension induce movement of mRNA and ribosomes to focal adhesions. Nature. 1998 Apr 16; 392(6677):730-3. View Abstract
  356. Cellular control lies in the balance of forces. Curr Opin Cell Biol. 1998 Apr; 10(2):232-9. View Abstract
  357. Extracellular matrix and pulmonary hypertension: control of vascular smooth muscle cell contractility. Am J Physiol. 1998 01; 274(1):H76-82. View Abstract
  358. In search of cellular control: signal transduction in context. J Cell Biochem Suppl. 1998; 30-31:232-7. View Abstract
  359. The architecture of life. Sci Am. 1998 Jan; 278(1):48-57. View Abstract
  360. In search of cellular control: Signal transduction in context. J Cell Biochem. 1998; 72 Suppl 30-31(S30-31):232-237. View Abstract
  361. Using microcontact printing to pattern the attachment of mammalian cells to self-assembled monolayers of alkanethiolates on transparent films of gold and silver. Exp Cell Res. 1997 Sep 15; 235(2):305-13. View Abstract
  362. Integrins, tensegrity, and mechanotransduction. Gravit Space Biol Bull. 1997 Jun; 10(2):49-55. View Abstract
  363. Geometric control of cell life and death. Science. 1997 May 30; 276(5317):1425-8. View Abstract
  364. Binding of urokinase to plasminogen activator inhibitor type-1 mediates cell adhesion and spreading. J Cell Sci. 1997 May; 110 ( Pt 9):1091-8. View Abstract
  365. Mechanical continuity and reversible chromosome disassembly within intact genomes removed from living cells. J Cell Biochem. 1997 Apr; 65(1):114-30. View Abstract
  366. Vinculin promotes cell spreading by mechanically coupling integrins to the cytoskeleton. Exp Cell Res. 1997 Feb 25; 231(1):14-26. View Abstract
  367. Demonstration of mechanical connections between integrins, cytoskeletal filaments, and nucleoplasm that stabilize nuclear structure. Proc Natl Acad Sci U S A. 1997 Feb 04; 94(3):849-54. View Abstract
  368. Cytoskeletal mechanics in pressure-overload cardiac hypertrophy. Circ Res. 1997 Feb; 80(2):281-9. View Abstract
  369. Tensegrity: the architectural basis of cellular mechanotransduction. Annu Rev Physiol. 1997; 59:575-99. View Abstract
  370. Integrin-dependent induction of early growth response genes in capillary endothelial cells. J Cell Sci. 1996 Dec; 109 ( Pt 12):2855-63. View Abstract
  371. Controlling cell attachment on contoured surfaces with self-assembled monolayers of alkanethiolates on gold. Proc Natl Acad Sci U S A. 1996 Oct 01; 93(20):10775-8. View Abstract
  372. A microstructural approach to cytoskeletal mechanics based on tensegrity. J Theor Biol. 1996 Jul 21; 181(2):125-36. View Abstract
  373. Integrin-dependent control of inositol lipid synthesis in vascular endothelial cells and smooth muscle cells. Exp Cell Res. 1996 Apr 10; 224(1):116-22. View Abstract
  374. Modulation of adhesion-dependent cAMP signaling by echistatin and alendronate. Biochem Biophys Res Commun. 1996 Apr 05; 221(1):19-24. View Abstract
  375. Leukocyte adhesion to vascular endothelium induces E-selectin linkage to the actin cytoskeleton. J Cell Biol. 1996 Apr; 133(2):445-55. View Abstract
  376. Direct binding of F actin to the cytoplasmic domain of the alpha 2 integrin chain in vitro. Biochem Biophys Res Commun. 1995 Dec 14; 217(2):466-74. View Abstract
  377. Cell shape, cytoskeletal mechanics, and cell cycle control in angiogenesis. J Biomech. 1995 Dec; 28(12):1471-84. View Abstract
  378. Convergence of integrin and growth factor receptor signaling pathways within the focal adhesion complex. Mol Biol Cell. 1995 Oct; 6(10):1349-65. View Abstract
  379. Probing transmembrane mechanical coupling and cytomechanics using magnetic twisting cytometry. Biochem Cell Biol. 1995 Jul-Aug; 73(7-8):327-35. View Abstract
  380. Cytoskeletal filament assembly and the control of cell spreading and function by extracellular matrix. J Cell Sci. 1995 Jun; 108 ( Pt 6):2311-20. View Abstract
  381. Extracellular matrix controls tubulin monomer levels in hepatocytes by regulating protein turnover. Mol Biol Cell. 1994 Dec; 5(12):1281-8. View Abstract
  382. Hollow fibers for hepatocyte encapsulation and transplantation: studies of survival and function in rats. Cell Transplant. 1994 Sep-Oct; 3(5):373-85. View Abstract
  383. Integrin binding and cell spreading on extracellular matrix act at different points in the cell cycle to promote hepatocyte growth. Mol Biol Cell. 1994 Sep; 5(9):967-75. View Abstract
  384. Control of cytoskeletal mechanics by extracellular matrix, cell shape, and mechanical tension. Biophys J. 1994 Jun; 66(6):2181-9. View Abstract
  385. Engineering cell shape and function. Science. 1994 Apr 29; 264(5159):696-8. View Abstract
  386. Electrically conducting polymers can noninvasively control the shape and growth of mammalian cells. Proc Natl Acad Sci U S A. 1994 Apr 12; 91(8):3201-4. View Abstract
  387. Integrating with integrins. Mol Biol Cell. 1994 Apr; 5(4):389-93. View Abstract
  388. Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470). Br J Cancer. 1994 Feb; 69(2):212-6. View Abstract
  389. Cellular tensegrity: exploring how mechanical changes in the cytoskeleton regulate cell growth, migration, and tissue pattern during morphogenesis. Int Rev Cytol. 1994; 150:173-224. View Abstract
  390. The riddle of morphogenesis: a question of solution chemistry or molecular cell engineering? Cell. 1993 Dec 31; 75(7):1249-52. View Abstract
  391. Prevascularization of porous biodegradable polymers. Biotechnol Bioeng. 1993 Sep 05; 42(6):716-23. View Abstract
  392. Rapid induction and isolation of focal adhesion complexes. Biochem Biophys Res Commun. 1993 Jun 15; 193(2):571-8. View Abstract
  393. Mechanotransduction across the cell surface and through the cytoskeleton. Science. 1993 May 21; 260(5111):1124-7. View Abstract
  394. Adhesion to fibronectin stimulates inositol lipid synthesis and enhances PDGF-induced inositol lipid breakdown. J Cell Biol. 1993 May; 121(3):673-8. View Abstract
  395. Cellular tensegrity: defining new rules of biological design that govern the cytoskeleton. J Cell Sci. 1993 Mar; 104 ( Pt 3):613-27. View Abstract
  396. Preparation of poly(glycolic acid) bonded fiber structures for cell attachment and transplantation. J Biomed Mater Res. 1993 Feb; 27(2):183-9. View Abstract
  397. Transplantation of genetically altered hepatocytes using cell-polymer constructs. Transplant Proc. 1993 Feb; 25(1 Pt 2):1002-4. View Abstract
  398. Altering the cellular mechanical force balance results in integrated changes in cell, cytoskeletal and nuclear shape. J Cell Sci. 1992 Dec; 103 ( Pt 4):1215-22. View Abstract
  399. Switching from differentiation to growth in hepatocytes: control by extracellular matrix. J Cell Physiol. 1992 Jun; 151(3):497-505. View Abstract
  400. Extracellular matrix as a solid-state regulator in angiogenesis: identification of new targets for anti-cancer therapy. Semin Cancer Biol. 1992 Apr; 3(2):57-63. View Abstract
  401. Inhibition of angiogenesis. Semin Cancer Biol. 1992 Apr; 3(2):89-96. View Abstract
  402. Extracellular matrix and cell shape: potential control points for inhibition of angiogenesis. J Cell Biochem. 1991 Nov; 47(3):236-41. View Abstract
  403. Integrins as mechanochemical transducers. Curr Opin Cell Biol. 1991 Oct; 3(5):841-8. View Abstract
  404. Insoluble fibronectin activates the Na/H antiporter by clustering and immobilizing integrin alpha 5 beta 1, independent of cell shape. Proc Natl Acad Sci U S A. 1991 Sep 01; 88(17):7849-53. View Abstract
  405. Multiple integrins share the ability to induce elevation of intracellular pH. Exp Cell Res. 1991 Aug; 195(2):533-5. View Abstract
  406. Hepatocyte culture on biodegradable polymeric substrates. Biotechnol Bioeng. 1991 Jun 20; 38(2):145-58. View Abstract
  407. Tissue engineering by cell transplantation using degradable polymer substrates. J Biomech Eng. 1991 May; 113(2):143-51. View Abstract
  408. Control of capillary growth and differentiation by extracellular matrix. Use of a tensegrity (tensional integrity) mechanism for signal processing. Chest. 1991 Mar; 99(3 Suppl):34S-40S. View Abstract
  409. Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent. Biochem Biophys Res Commun. 1991 Feb 14; 174(3):1070-6. View Abstract
  410. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature. 1990 Dec 06; 348(6301):555-7. View Abstract
  411. Control of intracellular pH and growth by fibronectin in capillary endothelial cells. J Cell Biol. 1990 May; 110(5):1803-11. View Abstract
  412. Fibronectin controls capillary endothelial cell growth by modulating cell shape. Proc Natl Acad Sci U S A. 1990 May; 87(9):3579-83. View Abstract
  413. Inhibition of tumor-cell attachment to extracellular matrix as a method for preventing tumor recurrence in a surgical wound. Ann Surg. 1989 Dec; 210(6):758-64. View Abstract
  414. How does extracellular matrix control capillary morphogenesis? Cell. 1989 Sep 08; 58(5):803-5. View Abstract
  415. Metabolism of tumor regression from angiogenesis inhibition: 31P magnetic resonance spectroscopy. Magn Reson Med. 1989 Aug; 11(2):202-8. View Abstract
  416. Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: role of extracellular matrix. J Cell Biol. 1989 Jul; 109(1):317-30. View Abstract
  417. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature. 1989 May 04; 339(6219):58-61. View Abstract
  418. Inhibition of angiogenesis through modulation of collagen metabolism. Lab Invest. 1988 Jul; 59(1):44-51. View Abstract
  419. A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane. Am J Pathol. 1988 Feb; 130(2):393-400. View Abstract
  420. Angiostatic steroids. Method of discovery and mechanism of action. Ann Surg. 1987 Sep; 206(3):374-83. View Abstract
  421. Endothelial growth factors and extracellular matrix regulate DNA synthesis through modulation of cell and nuclear expansion. In Vitro Cell Dev Biol. 1987 May; 23(5):387-94. View Abstract
  422. Regulation of endothelial growth factor action: solid state control by extracellular matrix. Prog Clin Biol Res. 1987; 249:273-82. View Abstract
  423. Heparin-binding angiogenesis factors: detection by immunological methods. Clin Physiol Biochem. 1987; 5(3-4):200-9. View Abstract
  424. A possible mechanism for inhibition of angiogenesis by angiostatic steroids: induction of capillary basement membrane dissolution. Endocrinology. 1986 Oct; 119(4):1768-75. View Abstract
  425. Basement membrane as a spatial organizer of polarized epithelia. Exogenous basement membrane reorients pancreatic epithelial tumor cells in vitro. Am J Pathol. 1986 Jan; 122(1):129-39. View Abstract
  426. Neoplastic disorganization of pancreatic epithelial cell-cell relations. Role of basement membrane. Am J Pathol. 1985 Nov; 121(2):248-60. View Abstract
  427. Music therapy: tune-up for mind and body. Sci Dig. 1982 Jan; 90(1):78. View Abstract
  428. Role of basal lamina in neoplastic disorganization of tissue architecture. Proc Natl Acad Sci U S A. 1981 Jun; 78(6):3901-5. View Abstract
  429. Cell surface properties of normal, differentiating, and neoplastic pancreatic acinar cells. Cancer. 1981 Mar 15; 47(6 Suppl):1516-27. View Abstract
  430. Enhancement of experimental lung metastases by cultured B16 melanoma cells treated with (+/-)-1,2-bis(3,5-dioxopiperazin-1-y)propane (ICRF-159). Cancer Res. 1978 Aug; 38(8):2263-70. View Abstract

Contact Donald Ingber

Phone: 617-919-2223
Fax: 617-730-0230